Oleg Gluz, PD Dr
Breast Centre, Evang. Bethesda-Hospital, Moenchengladbach · Westdeutsche Studiengruppe GmbH · Breast Centre, Evang. Bethesda-Hospital Moenchengladbach
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Oleg Gluz, PD Dr as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:02 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06081244 · NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)Women's Cancer Study Group GmbH · recruiting · Triple Negative Breast Cancer · principal investigator
- N/ANCT05792150 · PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFSWomen's Cancer Study Group GmbH · recruiting · Female Breast Cancer · principal investigator
- Ph2NCT05704829 · NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast CancerWomen's Cancer Study Group GmbH · recruiting · HER2-positive Early Breast Cancer · principal investigator
- Ph3NCT04565054 · Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBCWomen's Cancer Study Group GmbH · active not recruiting · Breast Cancer Female · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.